Keysight Technologies Inc <KEYS.N>: Morgan Stanley Raises Target Price to $400.00 From $350.00
KEYS•Related News
Edgewise Therapeutics sells sevasemten, muscular dystrophy business to Servier for up to $2.65 billion
EWTX•
Octagon urges XFLT shareholders to reject proposed King Street sub-adviser appointment
XFLT•
Johnson Controls schedules Q3 fiscal 2026 earnings call webcast
JCI•
Intapp names Lyra Schramm chief people and places officer
INTA•
Nasdaq trade halt continues <OST.O> reason not available at 09:31 AM
OST•